Sign In

Ed Shenkan

Healthcare Executive | Former FDA | Sell Side Analyst | Board Member

Ed Shenkan

Ed Shenkan is an experienced corporate director, healthcare financial analyst, strategic consultant, and pharmaceuticals operator with a deep knowledge of public and private healthcare companies.1 He currently serves as the CEO, Strategic Advisor and Consultant at Shenkan Advisors, a consulting firm he founded in May 2009.13

Key Highlights

  • Has FDA experience and an extensive network in the investment community1
  • Provides input on strategic planning, financial modeling, capital raising, product positioning, M&A opportunities, and exit strategies for boards1
  • Chairs public company Audit Committees and satisfies SEC requirements1
  • Assists healthcare company boards, management teams, and investors with strategic decisions and due diligence on acquisitions and investments using proprietary market research13
  • Advises institutional investors and companies on investment decisions, market assessments, and company valuations3
  • Surveys and interviews several thousand physicians, medical providers, administrators, and payors annually to incorporate qualitative and quantitative primary research into financial models and analysis3
  • Helps private equity investors and companies screen M&A, perform due diligence, and evaluate white spaces3
  • Develops business strategies to create long-term value and roadmaps for future bolt-on acquisitions3
  • Analyzes capital allocation decisions for boards and management teams3
  • Assists companies in developing strategic market assessments for existing and new markets3

Recent Roles

  • Associate Director FDA CDRH, General Manager Total Product Life Cycle Advisors Program (TAP) (October 2022 - November 2023)12
  • Launched the TAP program and its consulting practice to help breakthrough products obtain regulatory approval and market access1

Education

  • MBA, Harvard Business School
  • BA, Dartmouth College

Highlights

Jan 5 · JD Supra
The Life Sciences Report – January 2024 | Wilson Sonsini Goodrich & Rosati - JDSupra - JD Supra
The Life Sciences Report – January 2024 | Wilson Sonsini Goodrich & Rosati - JDSupra - JD Supra
MedTech Innovator Crowns MicroTransponder and Mirai Medical ...
MedTech Innovator Crowns MicroTransponder and Mirai Medical ...
Nov 17 · Business Wire
MedTech Innovator Crowns MicroTransponder and Mirai Medical ... - Business Wire
MedTech Innovator Crowns MicroTransponder and Mirai Medical ... - Business Wire
Jan 30 · mystrategist.com
FDA Hires Medtech Deals Expert to Run TAP Program - MyStrategist
FDA Hires Medtech Deals Expert to Run TAP Program - MyStrategist

Related Questions

What are some notable projects Ed Shenkan has led at Shenkan Advisors?
How did Ed Shenkan's experience at the FDA influence his consulting practice?
What specific industries does Shenkan Advisors focus on?
How does Shenkan Advisors conduct its market research?
What are the key services offered by Shenkan Advisors?
Ed Shenkan
Ed Shenkan, photo 1
Ed Shenkan, photo 2
Add to my network

Location

San Francisco, California, United States